Document is current
Any future updates will be listed below
-
Authors
Kappler, Benjamin https://orcid.org/0000-0001-6816-3162
Ledezma, Carlos A.
van Tuijl, Sjoerd
Meijborg, Veronique
Boukens, Bastiaan J.
Ergin, Bülent
Tan, P. J.
Stijnen, Marco
Ince, Can
Díaz-Zuccarini, Vanessa
de Mol, Bas A. J. M.
-
Funding
Funding for this research was provided by:
Horizon 2020 (No 642612, No 642612, No 642612, No 642612)
Hartstichting (2016T047)
- License Information
-
More Information
Article History
Received: 20 February 2019
Accepted: 31 October 2019
First Online: 11 November 2019
Ethics approval and consent to participate
: All protocols followed by the slaughterhouse and laboratory were consistent with EC regulations 1069/2009 regarding the use of slaughterhouse animal material for diagnosis and research, supervised by the Dutch Government (Dutch Ministry of Agriculture, Nature and Food Quality) and were approved by the associated legal authorities of animal welfare (Food and Consumer Product Safety Authority).
: Not applicable.
: B. Kappler worked with LifeTecGroup B.V. before his employment as PhD researcher at the department of Cardiothoracic Surgery of the Academic Medical Center at the University of Amsterdam. S. van Tuijl. is an employee of the LifeTec Group B.V. M. Stijnen and B.A.J.M. de Mol are founders of LifeTec Group BV and are respectively Head of Medtech Innovation and director of Medical Affairs. Professor B.A.J.M. de Mol was chief of the department of Cardio-thoracic Surgery at the Amsterdam University Medical Center. LifeTec Group B.V. developed the PhysioHeart™ platform and has the proprietary rights. LifeTecGroup BV supported this study with professional laboratory services and provision of materials.
